60 related articles for article (PubMed ID: 34667073)
21. Glomangiopericytoma: a case series with review of literature.
Kazi AA; McDougal EM; Howell JB; Schuman TA; Nord RS
Braz J Otorhinolaryngol; 2022; 88(5):817-820. PubMed ID: 33744192
[No Abstract] [Full Text] [Related]
22. Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1.
André F; Ciruelos EM; Juric D; Loibl S; Campone M; Mayer IA; Rubovszky G; Yamashita T; Kaufman B; Lu YS; Inoue K; Pápai Z; Takahashi M; Ghaznawi F; Mills D; Kaper M; Miller M; Conte PF; Iwata H; Rugo HS
Ann Oncol; 2021 Feb; 32(2):208-217. PubMed ID: 33246021
[TBL] [Abstract][Full Text] [Related]
23. Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal Cancer?
Prossomariti A; Piazzi G; Alquati C; Ricciardiello L
Cell Mol Gastroenterol Hepatol; 2020; 10(3):491-506. PubMed ID: 32334125
[TBL] [Abstract][Full Text] [Related]
24.
Fomchenko EI; Erson-Omay EZ; Zhao A; Bindra RS; Huttner A; Fulbright RK; Moliterno J
Cold Spring Harb Mol Case Stud; 2019 Aug; 5(4):. PubMed ID: 31371348
[TBL] [Abstract][Full Text] [Related]
25. The H1047R PIK3CA oncogene induces a senescence-like state, pleiotropy and acute HSP90 dependency in HER2+ mammary epithelial cells.
Chakrabarty A; Surendran S; Bhola NE; Mishra VS; Wani TH; Baghel KS; Arteaga CL; Garg R; Chowdhury G
Carcinogenesis; 2019 Oct; 40(10):1179-1190. PubMed ID: 31219154
[TBL] [Abstract][Full Text] [Related]
26. Sinonasal glomangiopericytoma: A clinicopathologic study.
Obeidin F; Jennings LJ; Alexiev BA
Pathol Res Pract; 2019 May; 215(5):983-987. PubMed ID: 30739805
[TBL] [Abstract][Full Text] [Related]
27. COSMIC: the Catalogue Of Somatic Mutations In Cancer.
Tate JG; Bamford S; Jubb HC; Sondka Z; Beare DM; Bindal N; Boutselakis H; Cole CG; Creatore C; Dawson E; Fish P; Harsha B; Hathaway C; Jupe SC; Kok CY; Noble K; Ponting L; Ramshaw CC; Rye CE; Speedy HE; Stefancsik R; Thompson SL; Wang S; Ward S; Campbell PJ; Forbes SA
Nucleic Acids Res; 2019 Jan; 47(D1):D941-D947. PubMed ID: 30371878
[TBL] [Abstract][Full Text] [Related]
28. Is immunohistochemical staining for β-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional study.
Koike H; Nishida Y; Kohno K; Shimoyama Y; Motoi T; Hamada S; Kawai A; Ogose A; Ozaki T; Kunisada T; Matsumoto Y; Matsunobu T; Ae K; Gokita T; Sakai T; Shimizu K; Ishiguro N
Hum Pathol; 2019 Feb; 84():155-163. PubMed ID: 30292627
[TBL] [Abstract][Full Text] [Related]
29. Glomangiopericytoma of the Nasal Cavity with CTNNB1 p.S37C Mutation: A Case Report and Literature Review.
Kono M; Bandoh N; Matsuoka R; Goto T; Akahane T; Kato Y; Nakano H; Yamaguchi T; Harabuchi Y; Nishihara H
Head Neck Pathol; 2019 Sep; 13(3):298-303. PubMed ID: 30206803
[TBL] [Abstract][Full Text] [Related]
30. A Case of Glomangiopericytoma at the Nasal Septum.
Anzai T; Saito T; Tsuyama S; Toh M; Ikeda K; Ito S
Head Neck Pathol; 2018 Dec; 12(4):572-575. PubMed ID: 29168109
[TBL] [Abstract][Full Text] [Related]
31. ClinVar: improving access to variant interpretations and supporting evidence.
Landrum MJ; Lee JM; Benson M; Brown GR; Chao C; Chitipiralla S; Gu B; Hart J; Hoffman D; Jang W; Karapetyan K; Katz K; Liu C; Maddipatla Z; Malheiro A; McDaniel K; Ovetsky M; Riley G; Zhou G; Holmes JB; Kattman BL; Maglott DR
Nucleic Acids Res; 2018 Jan; 46(D1):D1062-D1067. PubMed ID: 29165669
[TBL] [Abstract][Full Text] [Related]
32. Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer.
Solzak JP; Atale RV; Hancock BA; Sinn AL; Pollok KE; Jones DR; Radovich M
NPJ Breast Cancer; 2017; 3():17. PubMed ID: 28649657
[TBL] [Abstract][Full Text] [Related]
33. Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma.
Dreyling M; Morschhauser F; Bouabdallah K; Bron D; Cunningham D; Assouline SE; Verhoef G; Linton K; Thieblemont C; Vitolo U; Hiemeyer F; Giurescu M; Garcia-Vargas J; Gorbatchevsky I; Liu L; Koechert K; Peña C; Neves M; Childs BH; Zinzani PL
Ann Oncol; 2017 Sep; 28(9):2169-2178. PubMed ID: 28633365
[TBL] [Abstract][Full Text] [Related]
34. Characteristics and prognosis of glomangiopericytomas: A systematic review.
Park ES; Kim J; Jun SY
Head Neck; 2017 Sep; 39(9):1897-1909. PubMed ID: 28497509
[TBL] [Abstract][Full Text] [Related]
35. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Nasal Cavity, Paranasal Sinuses and Skull Base.
Stelow EB; Bishop JA
Head Neck Pathol; 2017 Mar; 11(1):3-15. PubMed ID: 28247233
[TBL] [Abstract][Full Text] [Related]
36. Dual PI3K/mTOR Inhibition in Colorectal Cancers with
Foley TM; Payne SN; Pasch CA; Yueh AE; Van De Hey DR; Korkos DP; Clipson L; Maher ME; Matkowskyj KA; Newton MA; Deming DA
Mol Cancer Res; 2017 Feb; 15(3):317-327. PubMed ID: 28184015
[TBL] [Abstract][Full Text] [Related]
37. SIFT missense predictions for genomes.
Vaser R; Adusumalli S; Leng SN; Sikic M; Ng PC
Nat Protoc; 2016 Jan; 11(1):1-9. PubMed ID: 26633127
[TBL] [Abstract][Full Text] [Related]
38. Recurrent mutations within the amino-terminal region of β-catenin are probable key molecular driver events in sinonasal hemangiopericytoma.
Haller F; Bieg M; Moskalev EA; Barthelmeß S; Geddert H; Boltze C; Diessl N; Braumandl K; Brors B; Iro H; Hartmann A; Wiemann S; Agaimy A
Am J Pathol; 2015 Feb; 185(2):563-71. PubMed ID: 25482924
[TBL] [Abstract][Full Text] [Related]
39. Nuclear expression and gain-of-function β-catenin mutation in glomangiopericytoma (sinonasal-type hemangiopericytoma): insight into pathogenesis and a diagnostic marker.
Lasota J; Felisiak-Golabek A; Aly FZ; Wang ZF; Thompson LD; Miettinen M
Mod Pathol; 2015 May; 28(5):715-20. PubMed ID: 25431235
[TBL] [Abstract][Full Text] [Related]
40. Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances.
Llorente JL; López F; Suárez C; Hermsen MA
Nat Rev Clin Oncol; 2014 Aug; 11(8):460-72. PubMed ID: 24935016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
